Ares Financial Consulting »

Atyr Pharma shares owned by Ares Financial Consulting

Quarter-by-quarter ownership of Atyr Pharma (ATYR) shares owned by Ares Financial Consulting from 13F filings

Historical chart of Ares Financial Consulting investment in Atyr Pharma

Tip: Access up to 7 years of quarterly data

All positions including Atyr Pharma held by Ares Financial Consulting consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Atyr Pharma by Ares Financial Consulting

Quarter filed Position value Share count Share price at filing
2026-03-31 $1.7k 2.0k 0.85

More positions owned by Ares Financial Consulting

Vanguard Total Stock Market Etf Etf (VTI)
Wisdomtree Floating Rate Treasury Fund Etf (USFR)
Dimensional U.s. Targeted Value Etf Etf (DFAT)
Dimensional Inflation-protected Securities Etf Etf (DFIP)
Dimensional International Core Equity Market Etf Etf (DFAI)
Nvidia Corporation Stock (NVDA)
Avantis U.s. Equity Etf Etf (AVUS)
Ishares 0-5 Year Tips Bond Etf Etf (STIP)
Pimco 15 Year Us Tips Index Exchange-traded Fund Etf (LTPZ)
Alphabet Inc Cap Stk Cl C Stock (GOOG)
Dimensional U.s. Core Equity 2 Etf Etf (DFAC)
Saba Closed End Funds Etf Etf (CEFS)
Vanguard Total International Stock Etf Etf (VXUS)
Apple Stock (AAPL)
Dimensional International Core Equity 2 Etf Etf (DFIC)

View all positions for Ares Financial Consulting

Top funds holding Atyr Pharma

FMR
Federated Investors
BlackRock
Vanguard Group
UBS Group
Vanguard Capital Management
Geode Capital Management
State Street Corporation
GSA Capital Partners
Millennium Management
Morgan Stanley
Two Sigma Investments
Susquehanna International
Rosalind Advisors
Northern Trust

View all funds holding Atyr Pharma